Anti-Indoleamine 2, 3-dioxygenase antibody (ab106134)

Publishing research using ab106134? Please let us know so that we can cite the reference in this datasheet.

ab106134 has been referenced in 5 publications.

  • Nagy-Grócz G  et al. The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat. Front Neurol 8:278 (2017). WB ; Rat . PubMed: 28659861
  • Bandeira LG  et al. Exogenous Tryptophan Promotes Cutaneous Wound Healing of Chronically Stressed Mice through Inhibition of TNF-a and IDO Activation. PLoS One 10:e0128439 (2015). Mouse . PubMed: 26057238
  • Wainwright DA  et al. Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. Clin Cancer Res 20:5290-301 (2014). PubMed: 24691018
  • Li H  et al. Cutting Edge: defective follicular exclusion of apoptotic antigens due to marginal zone macrophage defects in autoimmune BXD2 mice. J Immunol 190:4465-9 (2013). WB . PubMed: 23543760
  • Hill M  et al. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J 19:1957-68 (2005). Human, Rat . PubMed: 16319139

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up